Serum sickness‐like reaction following initiation of elexacaftor/tezacaftor/ivacaftor therapy-Reference-Cited by-同舟云学术

Serum sickness‐like reaction following initiation of elexacaftor/tezacaftor/ivacaftor therapy

Published:2020-09-21 Issue:11 Volume:55 Page:2846-2847
ISSN:8755-6863
Container-title:Pediatric Pulmonology
language:en
Short-container-title:Pediatr Pulmonol

Author:

Brennan Steven¹^ORCID,Marmor Itay²,Schafer Christine³,Ko James³,Torres Garcia José A.¹,Rosman Ilana S.³⁴,Coughlin Carrie³,Coverstone Andrea¹^ORCID,White Andrew J.²

Affiliation:

1. Edward Mallinckrodt Department of Pediatrics, Division of Allergy, Immunology, and Pulmonary Medicine Washington University St. Louis Missouri USA

2. Edward Mallinckrodt Department of Pediatrics, Division of Rheumatology Washington University St. Louis Missouri USA

3. Department of Internal Medicine, Division of Dermatology Washington University St. Louis Missouri USA

4. Department of Immunology and Pathology Washington University St. Louis Missouri USA

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Pediatrics, Perinatology and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ppul.25072

Reference7 articles.

1. Elexacaftor–Tezacaftor–Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele

2. Serum sickness–like reaction: Histopathology and case report

3. Demographic and clinical characteristics of patients with serum sickness‐like reaction;Yorulmaz A;Clin Rheumatol,2017

4. Histopathological analysis and clinical correlation of drug reaction with eosinophilia and systemic symptoms (DRESS)

5. Pustular drug eruptions: a histopathological spectrum

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cutaneous manifestations of cystic fibrosis;Journal of the American Academy of Dermatology;2024-09

2. Elexacaftor-Tezacaftor-Ivacaftor: A Life-Changing Triple Combination of CFTR Modulator Drugs for Cystic Fibrosis;Pharmaceuticals;2023-03-08

3. A case of Elexacaftor-Tezacaftor-Ivacaftor induced rash resolving without interruption of treatment;Journal of Cystic Fibrosis;2022-11

4. If At First You Don't Succeed, Trikafta Again;The Journal of Pediatric Pharmacology and Therapeutics;2022-05-01

5. Management of Individual Patient Expectations When Starting with Highly Effective CFTR Modulators;Journal of Personalized Medicine;2021-08-19